Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Beta Bionics, Inc. (BBNX) is the subject of Amendment No. 3 to a beneficial-ownership report by Soleus-affiliated funds and managers and Guy Levy. Guy Levy reported beneficial ownership of 4,828,619 shares, or 8.7%. Soleus Capital Management, L.P. and Soleus GP, LLC each reported 4,787,198 shares, or 8.6%.
Soleus Capital Master Fund, L.P. reported 3,783,237 shares, while Soleus Private Equity Fund II, L.P. reported 1,003,961 shares. These positions overlap through the affiliated entities’ shared reporting authority. The reported percentages use 54,367,067 shares outstanding as of October 26, 2026.
Key Figures
Guy Levy beneficial ownership:4,828,619 sharesGuy Levy ownership percentage:8.7%Soleus Private Equity Fund II beneficial ownership:1,003,961 shares+5 more
8 metrics
Guy Levy beneficial ownership4,828,619 sharesReported amount
Guy Levy ownership percentage8.7%Percentage of class
Soleus Private Equity Fund II beneficial ownership1,003,961 sharesReported amount
Soleus Private Equity Fund II ownership percentage1.8%Percentage of class
Soleus Capital Master Fund beneficial ownership3,783,237 sharesIncludes shares issuable upon exercise of pre-funded warrants
Soleus Capital Master Fund ownership percentage6.8%Percentage of class
Shares issuable upon exercise of pre-funded warrants1,043,484 sharesHeld by Soleus Capital Master Fund and included in its reported beneficial ownership
Shares outstanding54,367,067 sharesAs of October 26, 2026; basis for the reported ownership percentages
"Aggregate Amount Beneficially Owned by Each Reporting Person"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
shared voting powerregulatory
"Shared Voting Power 1,003,961.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerregulatory
"Shared Dispositive Power 1,003,961.00"
pre-funded warrantsfinancial
"shares issuable upon the exercise of pre-funded warrants"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many BBNX shares did Guy Levy report beneficially owning?
Guy Levy reported beneficial ownership of 4,828,619 shares of BBNX common stock, equal to 8.7% of the class. The percentage was calculated using 54,367,067 shares outstanding as of October 26, 2026.
How many BBNX shares did Soleus Capital Master Fund report?
Soleus Capital Master Fund, L.P. reported beneficial ownership of 3,783,237 shares, including 1,043,484 shares issuable upon exercise of pre-funded warrants. The reported percentage for this position was 6.8%.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 3)
Beta Bionics, Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
08659B102
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
08659B102
1
Names of Reporting Persons
Soleus Private Equity Fund II, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,003,961.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,003,961.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,003,961.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.8 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus Private Equity Fund II, L.P. ("Soleus PE"). Soleus Private Equity GP II, LLC ("Soleus PE GP") is the sole general partner of Soleus PE, Soleus PE GP II, LLC is the sole manager of Soleus PE GP, Soleus Capital Management, L.P. ("SCM ") is the investment manager for Soleus PE and for Soleus Capital Master Fund, L.P. ("Master Fund"), and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP II, LLC and of Soleus GP, LLC. Each of Mr. Levy, Soleus PE GP II, LLC, Soleus PE GP, SCM and Soleus GP, LLC disclaims beneficial ownership of these shares held by Soleus PE other than for the purpose of determining their obligations under Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The percentage set forth in row 11 is calculated based upon 54,367,067 shares of the common stock of Beta Bionics, Inc. (the "Issuer") outstanding as of October 26, 2026, as set forth on the cover of the Issuer's Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2026 that was filed with the Securities and Exchange Commission on October 27, 2026 (the "Form 10-Q").
SCHEDULE 13G
CUSIP Number(s):
08659B102
1
Names of Reporting Persons
Soleus Private Equity GP II, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,003,961.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,003,961.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,003,961.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.8 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus PE. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP II, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP II, LLC and of Soleus GP, LLC. Each of Mr. Levy, Soleus PE GP II, LLC, Soleus PE GP, SCM and Soleus GP, LLC disclaims beneficial ownership of these shares held by Soleus PE other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The percentage set forth in row 11 is calculated based upon 54,367,067 shares of the common stock of the Issuer outstanding as of October 26, 2026, as set forth on the cover of the Form 10-Q.
SCHEDULE 13G
CUSIP Number(s):
08659B102
1
Names of Reporting Persons
Soleus PE GP II, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
1,003,961.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
1,003,961.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
1,003,961.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
1.8 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus PE. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP II, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP II, LLC and of Soleus GP, LLC. Each of Mr. Levy, Soleus PE GP II, LLC, Soleus PE GP, SCM and Soleus GP, LLC disclaims beneficial ownership of these shares held by Soleus PE other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The percentage set forth in row 11 is calculated based upon 54,367,067 shares of the common stock of the Issuer outstanding as of October 26, 2026, as set forth on the cover of the Form 10-Q.
SCHEDULE 13G
CUSIP Number(s):
08659B102
1
Names of Reporting Persons
Soleus Capital Master Fund, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
CAYMAN ISLANDS
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
3,783,237.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
3,783,237.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
3,783,237.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.8 %
12
Type of Reporting Person (See Instructions)
FI
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital, LLC is the sole general partner of Master Fund, Soleus Capital Group, LLC ("SCG") is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, LLC, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The number of shares reported in the table above include 1,043,484 shares of the common stock of the Issuer that are issuable upon the exercise of pre-funded warrants that are held by Master Fund (such shares of common stock, the "PFW Shares").
(3) The percentage set forth in row 11 is calculated based upon 54,367,067 shares of the common stock of the Issuer outstanding as of October 26, 2026, as set forth on the cover of the Form 10-Q.
SCHEDULE 13G
CUSIP Number(s):
08659B102
1
Names of Reporting Persons
Soleus Capital, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
3,783,237.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
3,783,237.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
3,783,237.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.8 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, LLC, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The number of shares reported in the table above include the PFW Shares.
(3) The percentage set forth in row 11 is calculated based upon 54,367,067 shares of the common stock of the Issuer outstanding as of October 26, 2026, as set forth on the cover of the Form 10-Q.
SCHEDULE 13G
CUSIP Number(s):
08659B102
1
Names of Reporting Persons
Soleus Capital Group, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
3,783,237.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
3,783,237.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
3,783,237.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.8 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Master Fund. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Soleus PE and for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of SCG and of Soleus GP, LLC. Each of SCG, Soleus Capital, LLC, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held by Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The number of shares reported in the table above include the PFW Shares.
(3) The percentage set forth in row 11 is calculated based upon 54,367,067 shares of the common stock of the Issuer outstanding as of October 26, 2026, as set forth on the cover of the Form 10-Q.
SCHEDULE 13G
CUSIP Number(s):
08659B102
1
Names of Reporting Persons
Soleus Capital Management, L.P.
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,787,198.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,787,198.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,787,198.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.6 %
12
Type of Reporting Person (See Instructions)
PN
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus PE and by Master Fund. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP II, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE, and Soleus GP, LLC is the sole general partner of SCM. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP II, LLC, SCG and Soleus GP, LLC. Each of Soleus PE GP, Soleus PE GP II, LLC, Soleus Capital, LLC, SCG, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held directly by Soleus PE and Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The number of shares reported in the table above include the PFW Shares.
(2) The percentage set forth in row 11 is calculated based upon 54,367,067 shares of the common stock of the Issuer outstanding as of October 26, 2026, as set forth on the cover of the Form 10-Q.
SCHEDULE 13G
CUSIP Number(s):
08659B102
1
Names of Reporting Persons
Soleus GP, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
4,787,198.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
4,787,198.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,787,198.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.6 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus PE and by Master Fund. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP II, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE, and Soleus GP, LLC is the sole general partner of SCM. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP II, LLC, SCG and Soleus GP, LLC. Each of Soleus PE GP, Soleus PE GP II, LLC, Soleus Capital, LLC, SCG, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held directly by Soleus PE and Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The number of shares reported in the table above include the PFW Shares.
(3) The percentage set forth in row 11 is calculated based upon 54,367,067 shares of the common stock of the Issuer outstanding as of October 26, 2026, as set forth on the cover of the Form 10-Q.
SCHEDULE 13G
CUSIP Number(s):
08659B102
1
Names of Reporting Persons
Levy Guy
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
41,421.00
6
Shared Voting Power
4,787,198.00
7
Sole Dispositive Power
41,421.00
8
Shared Dispositive Power
4,787,198.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
4,828,619.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
8.7 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: (1) The shares reported in the table above are held directly by Soleus PE and by Master Fund. Soleus PE GP is the sole general partner of Soleus PE, Soleus PE GP II, LLC is the sole manager of Soleus PE GP, SCM is the investment manager for Soleus PE, and Soleus GP, LLC is the sole general partner of SCM. Soleus Capital, LLC is the sole general partner of Master Fund, SCG is the sole managing member of Soleus Capital, LLC, SCM is the investment manager for Master Fund, and Soleus GP, LLC is the sole general partner of SCM. Guy Levy is the sole managing member of each of Soleus PE GP II, LLC, SCG and Soleus GP, LLC. Each of Soleus PE GP, Soleus PE GP II, LLC, Soleus Capital, LLC, SCG, SCM, Soleus GP, LLC and Mr. Levy disclaims beneficial ownership of these shares held directly by Soleus PE and Master Fund other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act, and the filing of this report shall not be deemed an admission that any of the foregoing persons is the beneficial owner of such shares for any other purpose.
(2) The number of shares reported in the table above include the PFW Shares.
(3) The percentage set forth in row 11 is calculated based upon 54,367,067 shares of the common stock of the Issuer outstanding as of October 26, 2026, as set forth on the cover of the Form 10-Q.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Beta Bionics, Inc.
(b)
Address of issuer's principal executive offices:
11 Hughes, Irvine, California 92618
Item 2.
(a)
Name of person filing:
Soleus Private Equity Fund II, L.P.
Soleus Private Equity GP II, LLC
Soleus PE GP II, LLC
Soleus Capital Master Fund, L.P.
Soleus Capital, LLC
Soleus Capital Group, LLC
Soleus Capital Management, L.P.
Soleus GP, LLC
Guy Levy
(b)
Address or principal business office or, if none, residence:
Soleus Private Equity Fund II, L.P., 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus Private Equity GP II, LLC, 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus PE GP II, LLC, 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus Capital Master Fund, L.P., 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus Capital, LLC, 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus Capital Group, LLC, 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus Capital Management, L.P., 100 Field Point Road, Suite 200, Greenwich, CT 06830
Soleus GP, LLC, 100 Field Point Road, Suite 200, Greenwich, CT 06830
Guy Levy, c/o Soleus Capital Management, L.P., 100 Field Point Road, Suite 200, Greenwich, CT 06830
(c)
Citizenship:
Soleus Private Equity Fund II, L.P. - Delaware
Soleus Private Equity GP II, LLC - Delaware
Soleus PE GP II, LLC - Delaware
Soleus Capital Master Fund, L.P. - Cayman Islands
Soleus Capital, LLC - Delaware
Soleus Capital Group, LLC - Delaware
Soleus Capital Management, L.P. - Delaware
Soleus GP, LLC - Delaware
Guy Levy - United States
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
08659B102
Item 4.
Ownership
(a)
Amount beneficially owned:
The information in rows 5 through 9 and 11 on the cover pages to this Schedule 13G, including the footnotes thereto, which reflects beneficial ownership of the Common Stock of the Issuer, is hereby incorporated by reference.
Soleus Private Equity Fund II, L.P. - 1,003,961
Soleus Private Equity GP II, LLC - 1,003,961
Soleus PE GP II, LLC - 1,003,961
Soleus Capital Master Fund, L.P. - 3,783,237
Soleus Capital, LLC - 3,783,237
Soleus Capital Group, LLC - 3,783,237
Soleus Capital Management, L.P. - 4,787,198
Soleus GP, LLC - 4,787,198
Guy Levy - 4,828,619
(b)
Percent of class:
Soleus Private Equity Fund II, L.P. - 1.8%
Soleus Private Equity GP II, LLC - 1.8%
Soleus PE GP II, LLC - 1.8%
Soleus Capital Master Fund, L.P. - 6.8%
Soleus Capital, LLC - 6.8%
Soleus Capital Group, LLC - 6.8%
Soleus Capital Management, L.P. - 8.6%
Soleus GP, LLC - 8.6%
Guy Levy - 8.7%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
Guy Levy - 41,421
(ii) Shared power to vote or to direct the vote:
Soleus Private Equity Fund II, L.P. - 1,003,961
Soleus Private Equity GP II, LLC - 1,003,961
Soleus PE GP II, LLC - 1,003,961
Soleus Capital Master Fund, L.P. - 3,783,237
Soleus Capital, LLC - 3,783,237
Soleus Capital Group, LLC - 3,783,237
Soleus Capital Management, L.P. - 4,787,198
Soleus GP, LLC - 4,787,198
Guy Levy - 4,828,619
(iii) Sole power to dispose or to direct the disposition of:
Guy Levy - 41,421
(iv) Shared power to dispose or to direct the disposition of:
Soleus Private Equity Fund II, L.P. - 1,003,961
Soleus Private Equity GP II, LLC - 1,003,961
Soleus PE GP II, LLC - 1,003,961
Soleus Capital Master Fund, L.P. - 3,783,237
Soleus Capital, LLC - 3,783,237
Soleus Capital Group, LLC - 3,783,237
Soleus Capital Management, L.P. - 4,787,198
Soleus GP, LLC - 4,787,198
Guy Levy - 4,828,619
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Soleus Private Equity Fund II, L.P.
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy/Managing Member of the Sole Manager of the General Partner of Soleus Private Equity Fund II, L.P.
Date:
11/09/2026
Soleus Private Equity GP II, LLC
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy/Managing Member of the Sole Manager of Soleus Private Equity GP II, LLC
Date:
11/09/2026
Soleus PE GP II, LLC
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy/Managing Member
Date:
11/09/2026
Soleus Capital Master Fund, L.P.
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy/Managing Member of the Managing Member of the General Partner of Soleus Capital Master Fund, L.P.
Date:
11/09/2026
Soleus Capital, LLC
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy/Managing Member of the Managing Member of Soleus Capital, LLC
Date:
11/09/2026
Soleus Capital Group, LLC
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy/Managing Member
Date:
11/09/2026
Soleus Capital Management, L.P.
Signature:
/s/ Guy Levy
Name/Title:
Guy Levy/Managing Member of the General Partner of Soleus Capital Management, L.P.
